JP2012131740A - Granular bath agent composition - Google Patents
Granular bath agent composition Download PDFInfo
- Publication number
- JP2012131740A JP2012131740A JP2010285331A JP2010285331A JP2012131740A JP 2012131740 A JP2012131740 A JP 2012131740A JP 2010285331 A JP2010285331 A JP 2010285331A JP 2010285331 A JP2010285331 A JP 2010285331A JP 2012131740 A JP2012131740 A JP 2012131740A
- Authority
- JP
- Japan
- Prior art keywords
- mass
- oil
- agent composition
- nonionic surfactant
- bath agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013040 bath agent Substances 0.000 title claims abstract description 34
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 29
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims abstract description 23
- 150000007524 organic acids Chemical class 0.000 claims abstract description 18
- 239000003232 water-soluble binding agent Substances 0.000 claims abstract description 15
- 239000008187 granular material Substances 0.000 claims abstract description 8
- -1 sucrose fatty acid ester Chemical class 0.000 claims description 50
- 239000003921 oil Substances 0.000 claims description 33
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 25
- 239000000194 fatty acid Substances 0.000 claims description 25
- 229930195729 fatty acid Natural products 0.000 claims description 25
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 20
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 12
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 7
- 150000005215 alkyl ethers Chemical class 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 239000001530 fumaric acid Substances 0.000 claims description 6
- 239000004359 castor oil Substances 0.000 claims description 5
- 235000019438 castor oil Nutrition 0.000 claims description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 5
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- 239000011975 tartaric acid Substances 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- 239000001384 succinic acid Substances 0.000 claims description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 62
- 239000001569 carbon dioxide Substances 0.000 abstract description 31
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract description 31
- 239000006260 foam Substances 0.000 abstract description 4
- 239000002245 particle Substances 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 235000019198 oils Nutrition 0.000 description 29
- 239000007789 gas Substances 0.000 description 15
- 238000003287 bathing Methods 0.000 description 13
- 238000000034 method Methods 0.000 description 12
- 238000005187 foaming Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000003788 bath preparation Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 2
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BODMYPYTCKYRSP-UHFFFAOYSA-N 1,1-dioctylcyclohexane Chemical compound CCCCCCCCC1(CCCCCCCC)CCCCC1 BODMYPYTCKYRSP-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- FVKRIDSRWFEQME-UHFFFAOYSA-N 3-methylbutyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCC(C)C FVKRIDSRWFEQME-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- NDKYEUQMPZIGFN-UHFFFAOYSA-N Butyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCC NDKYEUQMPZIGFN-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 206010016334 Feeling hot Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 229960000250 adipic acid Drugs 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- LRMHFDNWKCSEQU-UHFFFAOYSA-N ethoxyethane;phenol Chemical compound CCOCC.OC1=CC=CC=C1 LRMHFDNWKCSEQU-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940074050 glyceryl myristate Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940078565 isoamyl laurate Drugs 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 1
- 229940073769 methyl oleate Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940116315 oxalic acid Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000010675 spruce oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- JREYOWJEWZVAOR-UHFFFAOYSA-N triazanium;[3-methylbut-3-enoxy(oxido)phosphoryl] phosphate Chemical compound [NH4+].[NH4+].[NH4+].CC(=C)CCOP([O-])(=O)OP([O-])([O-])=O JREYOWJEWZVAOR-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、粒状浴用剤組成物に関する。 The present invention relates to a granular bath agent composition.
炭酸塩と有機酸を配合した浴用剤は、浴水中で炭酸ガスの泡を発生し、当該炭酸ガスによる血行促進効果が得られることから、優れた浴用剤として広く知られている。このような浴用剤においては、浴水中で発生した炭酸ガスの濃度を高める手段として、浴槽の底部付近で浴用剤を溶解させるために、その形態を粒状ではなく、比較的大型の錠剤型とすることが多い。 A bath agent containing a carbonate and an organic acid is widely known as an excellent bath agent because it generates bubbles of carbon dioxide gas in the bath water and the blood circulation promoting effect by the carbon dioxide gas is obtained. In such a bath preparation, as a means for increasing the concentration of carbon dioxide gas generated in the bath water, in order to dissolve the bath preparation in the vicinity of the bottom of the bathtub, the form is not granular but a relatively large tablet type. There are many cases.
浴用剤の他の形態である粒状発泡性浴用剤は、打錠等の特殊な製造技術を必要としないこと、一般に溶解時間が短いこと等から、使用状態や好みにより錠剤型と使い分けられており、種々の研究がなされている。例えば、発泡性と保存安定性のために特定の含有量で油性成分を配合して、一定の平均粒子径範囲の顆粒とする技術(特許文献1)が報告されている。 The granular foaming bath agent, which is another form of bath agent, does not require special manufacturing technology such as tableting, and generally has a short dissolution time, so it is used separately from the tablet type depending on the usage condition and preference. Various studies have been conducted. For example, a technique (Patent Document 1) has been reported in which an oil component is blended with a specific content for foamability and storage stability to form granules having a certain average particle size range.
しかしながら、近年、オフィスのIT化の進歩等に伴い、一年を通じて冷え性等の不調に悩まされるヒトの数が増加傾向にあることも相まって、粒状浴用剤においても入浴後における温まり感の更なる向上が期待されている。 However, in recent years, with the advancement of IT in offices, etc., the number of people suffering from poor cooling, etc. is increasing throughout the year, and even in the case of granular bath preparations, the feeling of warmth after bathing is further improved. Is expected.
従って、本発明の課題は、斯かる実情に鑑み、入浴後に優れた温まり感をもたらす粒状浴用剤組成物を提供することにある。 Therefore, in view of such circumstances, an object of the present invention is to provide a granular bath agent composition that provides an excellent warm feeling after bathing.
本発明者らは上記課題を解決すべく種々検討した結果、炭酸塩と有機酸に特定量の非イオン界面活性剤を含有させて造粒物とし、当該造粒物と炭酸塩とを組み合せて用いれば、浴水中で発生する炭酸ガスの泡を極めて微細なものにすることができ、浴水中に多量の炭酸ガスが溶解して入浴後に優れた温まり感が得られることを見出し、本発明を完成した。
すなわち、本発明は、次の成分(A)並びに(B):
(A)有機酸、水溶性バインダー及び4〜30質量%の非イオン界面活性剤を含む造粒物、並びに
(B)炭酸塩
を含有する粒状浴用剤組成物を提供するものである。
As a result of various studies to solve the above-mentioned problems, the present inventors made a granulated product by adding a specific amount of a nonionic surfactant to carbonate and an organic acid, and combined the granulated product and the carbonate. If used, the bubbles of carbon dioxide generated in the bath water can be made extremely fine, and a large amount of carbon dioxide dissolves in the bath water and an excellent warm feeling after bathing is obtained. completed.
That is, the present invention includes the following components (A) and (B):
(A) A granulated product containing an organic acid, a water-soluble binder and 4 to 30% by mass of a nonionic surfactant, and (B) a granular bath composition containing a carbonate.
本発明の粒状浴用剤組成物によれば、微細な炭酸ガスの泡が多量に発生するため、浴水中に多量の炭酸ガスが溶け込み、入浴後に優れた温まり感をもたらすことができる。また、本発明の粒状浴用剤組成物は、浴水に投入後直ちに優れた溶解性を示すため、溶け残りを充分に抑制でき、使用感も好適である。 According to the granular bath agent composition of the present invention, a large amount of fine carbon dioxide gas bubbles are generated, so that a large amount of carbon dioxide gas dissolves in the bath water, and an excellent warm feeling can be provided after bathing. Moreover, since the granular bath agent composition of this invention shows the outstanding solubility immediately after throwing into bath water, it can fully suppress a melt | dissolution residue and its usability | use_condition is also suitable.
以下、本発明について詳細に説明する。
本発明の粒状浴用剤組成物に含まれる成分(A)は、(a1)有機酸、(a2)水溶性バインダー及び(a3)4〜30質量%の非イオン界面活性剤を含有する造粒物である(以下、造粒物(A)ともいう)。
Hereinafter, the present invention will be described in detail.
The component (A) contained in the granular bath composition of the present invention comprises (a1) an organic acid, (a2) a water-soluble binder, and (a3) 4 to 30% by mass of a nonionic surfactant. (Hereinafter also referred to as granulated product (A)).
本発明で用いる(a1)有機酸としては、リンゴ酸、酒石酸、クエン酸、マレイン酸、コハク酸、フタル酸、フマル酸、グルタル酸、アジピン酸、安息香酸、サリチル酸、ピロリドンカルボン酸及びシュウ酸等の室温(25℃)で固体の有機酸が好ましい。これらを1種単独で用いてもよく、2種以上組み合せて用いてもよい。なかでも、浴水中での溶解性及び製造時や使用時のハンドリング性の観点から、フマル酸、コハク酸及び酒石酸が好ましい。特に、(a1)有機酸全量を100質量%としたときのフマル酸の含有量は、40質量%以上が好ましく、60〜100質量%がより好ましく、80〜100質量%が特に好ましい。 Examples of the organic acid (a1) used in the present invention include malic acid, tartaric acid, citric acid, maleic acid, succinic acid, phthalic acid, fumaric acid, glutaric acid, adipic acid, benzoic acid, salicylic acid, pyrrolidone carboxylic acid and oxalic acid. Organic acids that are solid at room temperature (25 ° C.) are preferred. These may be used alone or in combination of two or more. Of these, fumaric acid, succinic acid and tartaric acid are preferred from the viewpoints of solubility in bath water and handling during production and use. In particular, the content of fumaric acid when the total amount of (a1) organic acid is 100% by mass is preferably 40% by mass or more, more preferably 60 to 100% by mass, and particularly preferably 80 to 100% by mass.
造粒物(A)中の(a1)有機酸の含有量は、炭酸ガス発生量の点から40〜95質量%が好ましく、60〜90質量%がより好ましい。また、(a1)有機酸の吸油能は、特に造粒物(A)中に油性成分を配合した場合に、油性成分を安定化して微細発泡を良好に進行させる観点から、吸油能が0.02mL/g以上のものが好ましく、0.05mL/g以上のものがより好ましい。吸油能とは、後述する実施例に記載の方法により決定される値である。なお、吸油能の上限は、粒子強度の観点から1.0mL/g以下であることが望ましい。 The content of the (a1) organic acid in the granulated product (A) is preferably 40 to 95% by mass, and more preferably 60 to 90% by mass from the viewpoint of the amount of carbon dioxide gas generated. In addition, (a1) the oil absorption capacity of the organic acid is, in particular, when the oil component is blended in the granulated product (A), from the viewpoint of stabilizing the oil component and favorably promoting fine foaming. The thing of 02 mL / g or more is preferable, and the thing of 0.05 mL / g or more is more preferable. The oil absorption capacity is a value determined by the method described in Examples described later. The upper limit of the oil absorption capacity is desirably 1.0 mL / g or less from the viewpoint of particle strength.
本発明で用いる(a2)水溶性バインダーは、前述した(a1)有機酸と後述する特定量の(a3)非イオン界面活性剤と共に用いられることで、造粒物の溶解性を制御して泡のより一層の微細化や発泡性に有効に作用すると共に、造粒物の強度をも高める。また、有機酸が水溶性バインダーによって被覆されることで、保存中に造粒物(A)中の有機酸と主に造粒物外に存在する炭酸塩とが接触して反応することが抑制され、炭酸ガスの発生により包装容器が膨張する等の問題が発生するのを防止し、保存安定性を向上させることができる。 The (a2) water-soluble binder used in the present invention is used together with the above-mentioned (a1) organic acid and a specific amount of (a3) nonionic surfactant to be described later, thereby controlling the solubility of the granulated product. This effectively acts on further refinement and foaming of the material and increases the strength of the granulated product. In addition, the organic acid is coated with a water-soluble binder to prevent the organic acid in the granulated product (A) from contacting and reacting with the carbonate present mainly outside the granulated product during storage. In addition, problems such as expansion of the packaging container due to the generation of carbon dioxide gas can be prevented and storage stability can be improved.
(a2)水溶性バインダーとしては、熱可塑性のものが好ましく、このような熱可塑性の(a2)水溶性バインダーとしては、ポリエチレングリコール、ポリプロピレングリコール、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンフェノールエーテルが好ましく、ポリエチレングリコール、ポリプロピレングリコールが特に好ましい。 The (a2) water-soluble binder is preferably a thermoplastic one, and the thermoplastic (a2) water-soluble binder is preferably polyethylene glycol, polypropylene glycol, polyoxyethylene alkyl ether, or polyoxyethylene phenol ether. Polyethylene glycol and polypropylene glycol are particularly preferable.
また、(a2)水溶性バインダーの数平均分子量は、粉末化を行う際の粘度調整とハンドリング性の観点から、ポリスチレンを標準としたGPC法で、4,000〜20,000が好ましく、6,000〜13,000がより好ましく、7,000〜9,000がさらに好ましい。水溶性バインダーとして、ポリエチレングリコールの分子量を測定する場合には、溶媒として水/エタノールを用いた。 In addition, the number average molecular weight of the (a2) water-soluble binder is preferably 4,000 to 20,000 by GPC method using polystyrene as a standard from the viewpoints of viscosity adjustment and handling properties when powdered, 000 to 13,000 are more preferable, and 7,000 to 9,000 are more preferable. When measuring the molecular weight of polyethylene glycol as a water-soluble binder, water / ethanol was used as a solvent.
また、上記(a2)水溶性バインダーを用いる場合には、数平均分子量の異なる水溶性バインダーを2種以上組み合わせて用いてもよい。 Moreover, when using said (a2) water-soluble binder, you may use in combination of 2 or more types of water-soluble binders from which a number average molecular weight differs.
造粒物(A)中の(a2)水溶性バインダーの含有量は、2〜30質量%が好ましく、5〜20質量%がより好ましい。前記下限値以上であると、造粒したときの粒子強度が高くなり、製造時の輸送過程で造粒物が壊れ難くなる。前記上限値以下であると、浴水中での造粒物(A)の溶解性が向上し、微細発泡性が高められ充分な量の炭酸ガスが浴水中に溶け込んで、入浴後における温まり感が促進される。 2-30 mass% is preferable and, as for content of the (a2) water-soluble binder in granulated material (A), 5-20 mass% is more preferable. When the amount is not less than the lower limit, the particle strength when granulated is increased, and the granulated product is hardly broken during the transport process during production. When the amount is not more than the upper limit, the solubility of the granulated product (A) in the bath water is improved, the fine foaming property is enhanced, and a sufficient amount of carbon dioxide gas dissolves in the bath water, so that a feeling of warming after bathing is obtained. Promoted.
本発明で用いる(a3)非イオン界面活性剤は、造粒物(A)中に2〜30質量%含まれ、好ましくは3〜27質量%含まれ、より好ましくは5〜25質量%含まれる。(a3)非イオン界面活性剤を上記範囲内の量で含むことにより、(a2)水溶性バインダーとも相まって、造粒物(A)の浴水中での良好な溶解性を発揮させながら、微細な炭酸ガスの泡の発生を向上させることができる。そのため、浴水中に充分な量の炭酸ガスが溶け込んで、入浴後における優れた温まり感を充分に実感させることができ、且つ造粒物の溶け残りもない。 The nonionic surfactant (a3) used in the present invention is contained in the granulated product (A) in an amount of 2 to 30% by mass, preferably 3 to 27% by mass, more preferably 5 to 25% by mass. . (A3) By containing the nonionic surfactant in an amount within the above range, (a2) in combination with the water-soluble binder, while exhibiting good solubility of the granulated product (A) in the bath water, Generation of carbon dioxide bubbles can be improved. Therefore, a sufficient amount of carbon dioxide gas dissolves in the bath water, and the excellent warm feeling after bathing can be fully realized, and there is no undissolved residue of the granulated product.
上記(a3)非イオン界面活性剤としては、ショ糖脂肪酸エステル、グリセリン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビトール脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルケニルエーテル、ポリオキシエチレンポリオキシプロピレングリコール、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレンアルケニルエーテル、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリグリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシプロピレンアルキルエーテル等が挙げられる。非イオン界面活性剤は1種単独で用いてもよいが、2種以上組み合わせて用いることにより、上記効果をさらに向上させることができるため好ましい。 Examples of the (a3) nonionic surfactant include sucrose fatty acid ester, glycerin fatty acid ester, propylene glycol fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbitol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene alkenyl. Ether, polyoxyethylene polyoxypropylene glycol, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene polyoxypropylene alkenyl ether, polyethylene glycol fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyglycerin fatty acid ester Sorbitan fatty acid ester, polyoxypropylene alkyl ether, and the like. A nonionic surfactant may be used alone, but it is preferable to use two or more nonionic surfactants in combination since the above effects can be further improved.
特に、微細な炭酸ガスの泡を大量に発生させ浴水中に充分な量の炭酸ガスが溶け込む点から、少なくともHLB6〜20の非イオン界面活性剤、より好ましくはHLB8〜19の非イオン界面活性剤、特に、HLB10〜18の非イオン界面活性剤を用いるのが好ましい。造粒物(A)中の非イオン界面活性剤全量を100質量%としたときのHLB6〜20の非イオン界面活性剤の含有量は、30〜100質量%が好ましく、40〜100質量%がより好ましく、50〜100質量%がさらに好ましい。 In particular, at least a nonionic surfactant of HLB6-20, more preferably a nonionic surfactant of HLB8-19, from the viewpoint that a large amount of fine carbon dioxide bubbles is generated and a sufficient amount of carbon dioxide dissolves in the bath water. In particular, it is preferable to use a nonionic surfactant of HLB 10-18. The content of the nonionic surfactant of HLB 6 to 20 when the total amount of the nonionic surfactant in the granulated product (A) is 100% by mass is preferably 30 to 100% by mass, and 40 to 100% by mass. More preferably, 50-100 mass% is further more preferable.
ここで、HLBは、界面活性剤の親水性と疎水性のバランスを表すのに通常使用される値であり、当分野において慣用される川上式等の幾つかの計算式により、求めることができる。本発明においては、下記の川上式を採用する。
HLB=7+11.7log(Mw/M0)
Mw:親水基の分子量
M0:疎水基の分子量
Here, HLB is a value usually used to represent the balance between the hydrophilicity and hydrophobicity of the surfactant, and can be obtained by several calculation formulas such as the Kawakami formula commonly used in this field. . In the present invention, the following Kawakami equation is adopted.
HLB = 7 + 11.7log (Mw / M0)
Mw: Molecular weight of hydrophilic group M0: Molecular weight of hydrophobic group
上記(a3)非イオン界面活性剤の中でも、ショ糖脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルケニルエーテル、ポリオキシエチレンソルビトール脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油等が好ましい。特に、ポリオキシエチレンアルキルエーテル及びポリオキシエチレンアルケニルエーテルから選ばれる1種以上の非イオン界面活性剤と、ポリオキシエチレンソルビトール脂肪酸エステル及びポリオキシエチレンソルビタン脂肪酸エステルから選ばれる1種以上の非イオン界面活性剤を組み合わせることが殊更好ましい。このようにすることで、非イオン界面活性剤の上記効果のうち、特に微細な炭酸ガスの泡の発生が著しく向上するため、浴水中への炭酸ガスの溶解を充分に促進し、入浴後における温まり感の促進効果をもたらす点で非常に好ましい。 Among the above (a3) nonionic surfactants, sucrose fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene alkenyl ether, polyoxyethylene sorbitol fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil, etc. Is preferred. In particular, at least one nonionic surfactant selected from polyoxyethylene alkyl ether and polyoxyethylene alkenyl ether, and at least one nonionic interface selected from polyoxyethylene sorbitol fatty acid ester and polyoxyethylene sorbitan fatty acid ester. It is particularly preferred to combine the activators. By doing so, among the above effects of the nonionic surfactant, particularly the generation of fine carbon dioxide bubbles is remarkably improved, so that the dissolution of carbon dioxide gas in the bath water is sufficiently promoted, and after bathing This is very preferable in that it provides a warming effect.
尚、本発明における造粒物(A)には、本発明の効果を阻害しない範囲内で、上記以外の成分を適宜配合することができる。そのような成分としては、油性成分、崩壊助剤、肌感触向上剤、消泡剤、酸化防止剤、分散剤、防菌・防黴剤、色素、生薬類等が挙げられる。 The granulated product (A) in the present invention can be appropriately mixed with components other than those described above as long as the effects of the present invention are not impaired. Examples of such components include oily components, disintegration aids, skin feel improvers, antifoaming agents, antioxidants, dispersants, antibacterial / antifungal agents, pigments, herbal medicines, and the like.
上記油性成分としては、具体的には、分子量が100以上でありClogP値が4〜18である脂肪酸エステルである、オクタン酸セチル、イソオクタン酸セチル、ラウリン酸ブチル、ラウリン酸イソアミル、ミリスチン酸メチル、ミリスチン酸エチル、ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸エチル、ステアリン酸ブチル、イソノナン酸イソトリデシル、イソノナン酸イソノニル、リノール酸イソプロピル、イソステアリン酸イソステアリル、イソステアリン酸イソプロピル、オレイン酸メチル、オレイン酸エチル、オレイン酸オレイル等が挙げられる。また、分子内に脂肪酸エステル構造を有するトリ(カプリル酸・カプリン酸)グリセリン、トリカプリル酸グリセリル等の脂肪酸グリセリド類;イソステアリン酸ポリグリセリル−2、トリイソステアリン酸ポリグリセリル−2等の脂肪酸ポリグリセリド類;大豆油、ヌカ油、ホホバ油、アボガド油、アーモンド油、オリーブ油、カカオ脂、ゴマ油、パーシック油、ヒマシ油、ヤシ油、ミンク油、牛脂、豚脂等の天然油脂、これらの天然油脂を水素添加して得られる硬化油及びミリスチン酸グリセリル、2−エチルヘキサン酸グリセリル等のグリセリド類等も挙げられる。分子量が100以上でありClogP値が4〜18である脂肪酸エステル以外の油性成分としては、流動パラフィン、ワセリン、パラフィン、マイクロクリスタリンワックス、セレシン、スクワラン、スクアレン、ジオクチルシクロヘキサン、ブリスタン等の炭化水素油;ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、オレイン酸、リノール酸、リノレン酸、ラノリン酸、イソステアリン酸等の高級脂肪酸類;ラウリルアルコール、セチルアルコール、ステアリルアルコール、オレイルアルコール、コレステロール、2−ヘキシルデカノール等の高級アルコール類;ハッカ油、ジャスミン油、ショウ脳油、ヒノキ油、トウヒ油、リュウ油、テレピン油、ケイ皮油、ベルガモット油、ミカン油、ショウブ油、パイン油、ラベンダー油、ベイ油、クローブ油、ヒバ油、バラ油、ユーカリ油、レモン油、タイム油、ペパーミント油、ローズ油、セージ油、メントール、シネオール、オイゲノール、シトラール、シトロネラール、ボルネオール、リナロール、ゲラーオール、カンファー、チモール、スピラントール、ピネン、リモネン、テルペン系化合物等の精油;シリコーン油類等が挙げられる。 Specifically, the oil component is a fatty acid ester having a molecular weight of 100 or more and a ClogP value of 4 to 18, cetyl octanoate, cetyl isooctanoate, butyl laurate, isoamyl laurate, methyl myristate, Ethyl myristate, isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, ethyl stearate, butyl stearate, isotridecyl isononanoate, isononyl isononanoate, isopropyl linoleate, isostearyl isostearate, isopropyl isostearate, methyl oleate, Examples include ethyl oleate and oleyl oleate. In addition, fatty acid glycerides such as tri (caprylic acid / capric acid) glycerin and glyceryl tricaprylate having a fatty acid ester structure in the molecule; fatty acid polyglycerides such as polyglyceryl-2 isostearate and polyglyceryl-2 triisostearate; soybean oil , Nuka oil, jojoba oil, avocado oil, almond oil, olive oil, cacao butter, sesame oil, persic oil, castor oil, coconut oil, mink oil, beef tallow, pork fat, and other natural fats and oils. Examples of the resulting oil include glycerides such as glyceryl myristate and glyceryl 2-ethylhexanoate. Examples of oil components other than fatty acid esters having a molecular weight of 100 or more and a ClogP value of 4 to 18 include hydrocarbon oils such as liquid paraffin, petrolatum, paraffin, microcrystalline wax, ceresin, squalane, squalene, dioctylcyclohexane, and bristan; Higher fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, linoleic acid, linolenic acid, lanolinic acid, isostearic acid; lauryl alcohol, cetyl alcohol, stearyl alcohol, oleyl alcohol, cholesterol, 2 -Higher alcohols such as hexyl decanol; peppermint oil, jasmine oil, ginger brain oil, cypress oil, spruce oil, ryu oil, turpentine oil, cinnamon oil, bergamot oil, mandarin oil, ginger oil, pine oil Lavender oil, bay oil, clove oil, hiba oil, rose oil, eucalyptus oil, lemon oil, thyme oil, rosemint oil, sage oil, menthol, cineole, eugenol, citral, citronellal, borneol, linalool, gellerall, Essential oils such as camphor, thymol, spirantol, pinene, limonene, terpene compounds; silicone oils and the like.
上記油性成分は、造粒物の保形性を保つ点や染み出し等製造時に生じる問題の点から、造粒物(A)中の2.5質量%未満、好ましくは、2質量%未満、特に好適には1質量%未満、さらに好適には0.5質量%未満であることが好ましい。殊更、油性成分は造粒物(A)中に含有しないことが最も好ましい。 The oil component is less than 2.5% by mass in the granulated product (A), preferably less than 2% by mass, from the point of maintaining the shape-retaining property of the granulated product and problems such as bleeding. It is particularly preferably less than 1% by mass, more preferably less than 0.5% by mass. Most preferably, the oil component is not contained in the granulated product (A).
なお、特に、造粒物(A)中の(a3)非イオン界面活性剤の含有量と油性成分の含有量との比率(油性成分/非イオン界面活性剤)が、好ましくは0〜1.0、さらに好ましくは0〜0.5であると、製造時の問題を抑制しつつ、入浴後における温まり感の促進効果をもたらす点で非常に有効である。 In particular, the ratio of the content of (a3) nonionic surfactant to the content of oil component in the granulated product (A) (oil component / nonionic surfactant) is preferably 0 to 1. When it is 0, more preferably 0 to 0.5, it is very effective in that the effect of warming after bathing is brought about while suppressing problems during production.
殊更に、(a3)非イオン界面活性剤としてポリオキシエチレンソルビトール脂肪酸エステルを含有する場合、造粒物(A)中のポリオキシエチレンソルビトール脂肪酸エステルの含有量と油性成分との比率(油性成分/ポリオキシエチレンソルビトール脂肪酸エステル)が、好ましくは0〜4.0、さらに好ましくは0〜1.0、特に好ましくは0〜0.5であると、製造時の問題を抑制しつつ、入浴後における温まり感の促進効果をもたらす点で非常に有効である。 In particular, when (a3) a polyoxyethylene sorbitol fatty acid ester is contained as a nonionic surfactant, the ratio of the content of the polyoxyethylene sorbitol fatty acid ester and the oil component in the granulated product (A) (oil component / The polyoxyethylene sorbitol fatty acid ester) is preferably 0 to 4.0, more preferably 0 to 1.0, and particularly preferably 0 to 0.5, while suppressing problems during production and after bathing. It is very effective in that it has the effect of promoting warmth.
造粒物(A)中に、さらに、崩壊助剤を配合することにより、造粒物(A)の崩壊性を向上させ、浴水中での造粒物(A)の溶解性を向上させることができる。崩壊助剤としては、常温(20℃)で固体の糖類や無機塩が好ましい。 By further adding a disintegration aid to the granulated product (A), the disintegration property of the granulated product (A) is improved and the solubility of the granulated product (A) in bath water is improved. Can do. As the disintegration aid, saccharides and inorganic salts which are solid at normal temperature (20 ° C.) are preferable.
糖類としては、ブドウ糖、果糖、乳糖、麦芽糖、蔗糖、デキストリン、マルトデキストリン、シクロデキストリン、マルトース、フルクトース、トレハロースが挙げられる。 Examples of the saccharide include glucose, fructose, lactose, maltose, sucrose, dextrin, maltodextrin, cyclodextrin, maltose, fructose, and trehalose.
無機塩としては、硫酸ナトリウム、硫酸マグネシウム、塩化ナトリウム、塩化カリウム、酸化マグネシウム、ポリリン酸ナトリウム、リン酸ナトリウムが挙げられるが、無機塩として炭酸塩を含んでいてもよいが、その場合は、造粒物(A)中の15質量%未満、好ましくは、保存安定性の点から2質量%未満、特に好適には1質量%未満、さらに好適には0.5質量%未満であることが好ましい。殊更、炭酸塩は造粒物(A)中に含有しないことが保存安定性の観点から最も好ましい。 Examples of the inorganic salt include sodium sulfate, magnesium sulfate, sodium chloride, potassium chloride, magnesium oxide, sodium polyphosphate, and sodium phosphate, and the inorganic salt may contain a carbonate. Less than 15% by mass in the granule (A), preferably less than 2% by mass, particularly preferably less than 1% by mass, more preferably less than 0.5% by mass from the viewpoint of storage stability. . In particular, the carbonate is most preferably not contained in the granulated product (A) from the viewpoint of storage stability.
崩壊助剤の粒径は、造粒物(A)を製造する際の造粒性、泡の微細化、発泡性、及び浴水中での溶解性の観点から、平均粒径が1μm〜100μmであるものを用いることが好ましく、特に押出し造粒にて造粒する場合には、平均粒径が3μm〜50μmであるものを用いることがより好ましく、平均粒径が5μm〜30μmであるものを用いることがさらに好ましい。上記に示す粒径よりも大きい場合には、好適な粒度になるまで事前に解砕することが好ましい。なお、崩壊助剤の平均粒径は実施例に記載の測定方法により決定される。 The average particle size of the disintegration aid is 1 μm to 100 μm from the viewpoint of granulation, finer foam, foamability, and solubility in bath water when the granulated product (A) is produced. It is preferable to use a certain one, and in particular, when granulating by extrusion granulation, it is more preferable to use one having an average particle size of 3 μm to 50 μm, and one having an average particle size of 5 μm to 30 μm is used. More preferably. When the particle size is larger than the above, it is preferable to disintegrate in advance until a suitable particle size is obtained. The average particle size of the disintegration aid is determined by the measurement method described in the examples.
造粒物(A)中の崩壊助剤の含有量は、溶解性の観点から、0.1質量%〜15量%が好ましく、1質量%〜10質量%がより好ましい。 From the viewpoint of solubility, the content of the disintegration aid in the granulated product (A) is preferably 0.1% by mass to 15% by mass, and more preferably 1% by mass to 10% by mass.
造粒物(A)の嵩密度は、本発明の浴用剤組成物を浴水に投与した際に、微細な炭酸ガスの発泡性を確保する観点から、700g/L以下であり、400〜700g/Lが好ましく、450〜650g/Lがより好ましい。本発明の嵩密度は、後述する(A)成分の製造時に圧密しすぎないことで達成できると考えられる。なお、(A)成分の造粒物の嵩密度はJIS K 3362により規定された方法により決定される。 The bulk density of the granulated product (A) is 700 g / L or less and 400 to 700 g from the viewpoint of securing the foamability of fine carbon dioxide gas when the bath agent composition of the present invention is administered to bath water. / L is preferable, and 450 to 650 g / L is more preferable. It is considered that the bulk density of the present invention can be achieved by not being too compact during the production of the component (A) described later. In addition, the bulk density of the granulated product of the component (A) is determined by a method defined by JIS K 3362.
さらに、造粒物(A)の平均粒径は、粉立ち、造粒物の溶解性及び沈降性の観点から、100〜1500μmが好ましく、400〜1200μmが好ましく、600〜900μmが好ましい。なお、造粒物(A)の平均粒径は実施例に記載の測定方法により決定される。 Furthermore, the average particle diameter of the granulated product (A) is preferably 100 to 1500 μm, preferably 400 to 1200 μm, and preferably 600 to 900 μm from the viewpoints of powdering, solubility of the granulated product, and sedimentation. In addition, the average particle diameter of a granulated material (A) is determined by the measuring method as described in an Example.
本発明の浴用剤組成物中の造粒物(A)の含有量は、炭酸ガスの浴水への溶解量、炭酸ガス発生量及び微細な炭酸ガスの泡を得る点から、30〜80質量%が好ましく、さらに35〜75質量%、特に40〜70質量%が好ましい。 The content of the granulated product (A) in the bath agent composition of the present invention is 30 to 80 mass from the viewpoint of obtaining the amount of carbon dioxide dissolved in the bath water, the amount of carbon dioxide generated and the fine carbon dioxide bubbles. %, More preferably 35 to 75% by mass, and particularly preferably 40 to 70% by mass.
本発明の粒状浴用剤組成物に含まれる成分(B)の炭酸塩としては、炭酸ジアルカリ金属塩である炭酸ナトリウムや炭酸カリウム等;炭酸水素塩である炭酸水素ナトリウム等;二価以上の金属の炭酸塩である炭酸カルシウム等が挙げられる。なかでも、微細な炭酸ガスの泡を発生させる点から、炭酸ジアルカリ金属塩を50〜100質量%含有するのが好ましく、さらに75〜100質量%含有するのが好ましく、またさらに80〜100質量%含有するのが好ましく、特に85〜100質量%含有するのが好ましい。炭酸ジアルカリ金属塩としては、炭酸ナトリウムが特に好ましく、炭酸水素塩としては、炭酸水素ナトリウムが特に好ましい。これらは1種単独で用いてもよく、2種以上組み合わせて用いてもよい。更に微細な炭酸ガスの泡を発生させる点から、炭酸水素塩を50質量以下%含有する炭酸塩が好ましい。さらに、成分(B)の炭酸塩中の炭酸水素塩の含有量は、より好ましくは0〜50質量%であり、さらに好ましくは0.01〜25質量%である。 Examples of the carbonate of the component (B) contained in the granular bath agent composition of the present invention include sodium carbonate and potassium carbonate which are dialkali metal carbonates; sodium hydrogen carbonate which is hydrogen carbonates; Examples thereof include calcium carbonate which is a carbonate. Among these, from the point of generating fine carbon dioxide gas bubbles, it is preferable to contain 50 to 100% by mass of a dialkali metal carbonate, more preferably 75 to 100% by mass, and further 80 to 100% by mass. It is preferable to contain, and it is preferable to contain especially 85-100 mass%. As the dialkali metal carbonate, sodium carbonate is particularly preferable, and as the hydrogen carbonate, sodium hydrogen carbonate is particularly preferable. These may be used alone or in combination of two or more. Further, a carbonate containing 50% by mass or less of hydrogen carbonate is preferable from the viewpoint of generating fine carbon dioxide bubbles. Furthermore, content of the hydrogen carbonate in the carbonate of a component (B) becomes like this. More preferably, it is 0-50 mass%, More preferably, it is 0.01-25 mass%.
成分(B)の炭酸塩の平均粒径は、泡の微細化、泡の持続時間、沈降性等の点から、100〜750μmが好ましく、さらに200〜500μm、特に250〜400μmであるのが好ましい。なお、成分(B)の炭酸塩の平均粒径は実施例に記載の測定方法により決定される。 The average particle diameter of the carbonate of the component (B) is preferably 100 to 750 μm, more preferably 200 to 500 μm, particularly preferably 250 to 400 μm, from the viewpoints of finer foam, duration of foam, sedimentation and the like. . In addition, the average particle diameter of the carbonate of a component (B) is determined by the measuring method as described in an Example.
本発明の粒状浴用剤組成物中の成分(B)である炭酸塩の含有量は、炭酸ガス発生量及び微細な炭酸ガスの泡を得る点から、20〜70質量%が好ましく、さらに25〜60質量%、特に30〜50質量%が好ましい。 The content of the carbonate which is the component (B) in the granular bath agent composition of the present invention is preferably 20 to 70% by mass, more preferably 25 to 25%, from the viewpoint of obtaining a carbon dioxide generation amount and fine carbon dioxide bubbles. 60% by mass, particularly 30 to 50% by mass is preferred.
本発明においては、本発明の効果を阻害しない範囲内で、通常浴用剤に用いられている成分を添加することができる。 In the present invention, components usually used in bath preparations can be added as long as the effects of the present invention are not impaired.
本発明の粒状浴用剤組成物では、成分(A)及び成分(B)がそれぞれ独立の粒子状態で存在するものである。ここで「独立の粒子状態で存在する」とは、それぞれ独立した別個の粒子状態の成分(A)及び成分(B)が混在した状態で存在することを意味するものであり、粒状浴用剤中では、成分(A)及び成分(B)が混在しており、一般的に粉状や顆粒状と呼ばれるものである。 In the granular bath agent composition of the present invention, the component (A) and the component (B) are present in independent particle states. Here, “existing in an independent particle state” means that the component (A) and the component (B) in separate and independent particle states exist in a mixed state. Then, the component (A) and the component (B) are mixed and are generally called powder or granule.
本発明の粒状浴用剤組成物は、通常の造粒手段、すなわち、成分(A)に用いる各成分を適宜混合した後に、押出造粒機や転動造粒機にて造粒することにより、造粒物(A)を製造し、さらに粒状の(B)炭酸塩及びその他の浴用剤組成物原料(C)を混合することにより製造できる。 The granular bath agent composition of the present invention is prepared by appropriately granulating each component used in normal granulation means, that is, component (A), and then granulating with an extrusion granulator or a tumbling granulator. The granulated product (A) can be produced, and further it can be produced by mixing the granular (B) carbonate and the other bath agent composition raw material (C).
本発明の粒状浴用剤組成物は、その0.01質量%水溶液の25℃におけるpHが5〜7、特に5.5〜6.5であることが好ましい。pHが5〜7であれば、発生した炭酸ガスが浴水中に溶け込み易く、入浴後に優れた温まり感等をもたらす効果が高められるからである。 The granular bath agent composition of the present invention preferably has a 0.01 mass% aqueous solution having a pH of 5 to 7, particularly 5.5 to 6.5 at 25 ° C. This is because, if the pH is 5 to 7, the generated carbon dioxide gas is easily dissolved in the bath water, and the effect of providing an excellent warm feeling after bathing is enhanced.
本発明の粒状浴用剤組成物は、浴水中に溶解した際に微細な炭酸ガスの泡が大量に発生する。微細な泡の発生は、浴水180リットル中に40〜60gの本発明の入浴剤組成物を溶解した際に、発生した炭酸ガスの泡により、浴水が速やかに白濁することから確認できる。この微細発泡の程度は、後述する実施例に記載の方法で測定する。 The granular bath agent composition of the present invention generates a large amount of fine carbon dioxide bubbles when dissolved in bath water. The generation of fine bubbles can be confirmed from the fact that the bath water quickly becomes cloudy due to the generated bubbles of carbon dioxide gas when 40 to 60 g of the bath agent composition of the present invention is dissolved in 180 liters of bath water. The degree of fine foaming is measured by the method described in the examples described later.
本発明の粒状浴用剤組成物は、浴水に溶解し、炭酸ガスの泡を発生させて使用する。特に、炭酸ガスの泡が生じているうちに入浴するのが好ましい。すなわち、成分(A)有機酸、水溶性バインダー及び4〜30質量%の非イオン界面活性剤を含む造粒物、並びに成分(B)炭酸塩を含有する粒状浴用剤組成物を浴水に投入して発泡を開始せしめ、発泡中又は発泡後浴水中に泡が残存している浴水に、身体の少なくとも一部を浸漬する方法であれば、本発明の効果が特に顕著に奏される。なお、本発明の浴用剤組成物は風呂等の全身浴はもちろん、足浴、腕浴等の部分浴としても使用できる。 The granular bath agent composition of the present invention is used by dissolving in bath water and generating bubbles of carbon dioxide gas. It is particularly preferable to take a bath while carbon dioxide bubbles are generated. That is, a granule containing a component (A) organic acid, a water-soluble binder and 4 to 30% by mass of a nonionic surfactant, and a granular bath agent composition containing component (B) carbonate are added to bath water. Thus, the effect of the present invention is particularly prominent if it is a method in which foaming is started and at least a part of the body is immersed in the bath water in which bubbles remain in the bath water during foaming or after foaming. The bath agent composition of the present invention can be used not only for a whole body bath such as a bath, but also as a partial bath such as a foot bath and an arm bath.
以下、本発明について、実施例に基づき具体的に説明するが、本発明はこれら実施例に限定されるものではない。 EXAMPLES Hereinafter, although this invention is demonstrated concretely based on an Example, this invention is not limited to these Examples.
<粒径>
粒径については、以下の2つの方法により測定した。
(1)造粒物(A)及び炭酸塩の粒径は、JIS K 8801の標準篩(目開き2000〜125μm)を用いて5分間振動させた後、篩目のサイズによる重量分率からメジアン径を算出した。
より詳細には、目開き125μm、180μm、250μm、355μm、500μm、710μm、1000μm、1400μm、2000μmの9段の篩と受け皿を用いて、受け皿上に目開きの小さな篩から順に積み重ね、最上部の2000μmの篩の上から100gの粒子を添加し、蓋をしてロータップ型ふるい振とう機(HEIKO製作所製、タッピング156回/分、ローリング:290回/分)に取り付け、5分間振動させたあと、それぞれの篩及び受け皿上に残留した該粒子の質量を測定し、各篩上の該粒子の質量割合(%)を算出した。
<Particle size>
The particle size was measured by the following two methods.
(1) The particle diameters of the granulated product (A) and carbonate are determined by the median from the weight fraction according to the size of the mesh after vibrating for 5 minutes using a standard sieve (mesh 2000 to 125 μm) of JIS K 8801. The diameter was calculated.
More specifically, using a 9-stage sieve and a tray with a mesh opening of 125 μm, 180 μm, 250 μm, 355 μm, 500 μm, 710 μm, 1000 μm, 1400 μm, and 2000 μm, the top of the top is stacked in order from the small sieve. Add 100 g of particles from the top of a 2000 μm sieve, cover and attach to a low-tap type sieve shaker (manufactured by HEIKO, tapping 156 times / minute, rolling: 290 times / minute), and shake for 5 minutes. The mass of the particles remaining on each sieve and the tray was measured, and the mass ratio (%) of the particles on each sieve was calculated.
(2)崩壊助剤の平均粒径測定は、レーザー回折/散乱式粒度分布測定装置LA−920(堀場製作所(株)製)を用い、該粒子を溶解させない溶媒に分散させて測定したメジアン径を平均粒径とした。尚、実施例に用いたフマル酸及び崩壊助剤の平均粒径測定には、溶媒としてアセトンを用いた。 (2) The average particle size of the disintegration aid was measured using a laser diffraction / scattering particle size distribution analyzer LA-920 (manufactured by Horiba, Ltd.), and the median diameter measured by dispersing the particles in a solvent that did not dissolve them. Was the average particle size. In addition, acetone was used as a solvent for the average particle diameter measurement of the fumaric acid and disintegration aid used in the examples.
<吸油能>
有機酸の吸油能測定は以下の方法で行った。吸収量測定器(あさひ総研製S410)に粉末を45g投入し、駆動羽根200rpmで回転させた。ここに油性成分及び非イオン界面活性剤を溶解した50℃混合液(花王(株)製エキセパールIPP 50質量%、花王(株)製エキセパールO−DM 15質量%、花王(株)製ルナックBA 5質量%、花王(株)製エマルゲン306P 10質量%、日光ケミカルズ(株)製ニッコールGO―440V 20質量%)を、液供給速度2mL/minで滴下し、最大トルクとなる点を見極めた。この最大トルクとなる点の70%のトルクとなる点での液添加量を粉末投入量で除算し、吸油能とした。
<Oil absorption capacity>
The oil absorption capacity of the organic acid was measured by the following method. 45 g of powder was put into an absorption measuring device (A410 manufactured by Asahi Research Institute) and rotated at a driving blade of 200 rpm. 50 ° C. mixed solution in which an oil component and a nonionic surfactant are dissolved (Exepal IPP 50% by mass, Kao Corp. Exepar O-DM 15% by mass, Lunac BA 5 manufactured by Kao Corp.) 10% by mass, 10% by mass of Emulgen 306P manufactured by Kao Corporation, and 20% by mass of Nikkor GO-440V manufactured by Nikko Chemicals Co., Ltd. were dropped at a liquid supply rate of 2 mL / min to determine the point at which the maximum torque was obtained. The liquid addition amount at the point where the torque becomes 70% of the point where the maximum torque is reached is divided by the amount of powder input to obtain the oil absorption capacity.
[実施例1〜10、比較例1〜3]
表1〜2に示す成分(A)に用いる成分を混合後押出造粒機にて嵩密度(500g/L〜600g/L)、平均粒径(700〜900μm)の造粒物を造粒し、(B)成分、さらに他の成分を混合して、粒状発泡性浴用剤を製造した。得られた各浴用剤について、下記方法に従って評価を行った。なお、用いたフマル酸の吸油能は0.082mL/g、ブドウ糖の平均粒径は20μm、炭酸塩の平均粒径は290μmであった。結果を表1〜2に示す。
[Examples 1 to 10, Comparative Examples 1 to 3]
After mixing the components used for the component (A) shown in Tables 1-2, a granulated product having a bulk density (500 g / L to 600 g / L) and an average particle size (700 to 900 μm) is granulated with an extrusion granulator. , (B) component and other components were mixed to produce a granular foaming bath agent. Each obtained bath agent was evaluated according to the following method. The fumaric acid used had an oil absorption capacity of 0.082 mL / g, glucose had an average particle size of 20 μm, and carbonate had an average particle size of 290 μm. The results are shown in Tables 1-2.
《微細発泡の程度(濁度)》
浴槽に40℃180Lのお湯を入れ、浴用剤組成物を投入し、充分に攪拌して、直径5cmの円形の黒色ゴム板を浴水に沈め、肉眼で完全に見えなくなる深度をにごり度(濁度)とし測定した。深度の数値(cm)が小さいほど、より微細な泡が生じていることを示す。
《Degree of fine foaming (turbidity)》
Put hot water of 40L at 40 ° C into the bath, add the bath preparation composition, stir well, submerge a circular black rubber plate with a diameter of 5cm in bath water to a depth that makes it completely invisible to the naked eye (turbidity) Degree) and measured. It shows that the finer bubble has arisen, so that the numerical value (cm) of depth is small.
《入浴後の温まり度合い》
20〜40才の女性合計10名のパネラーにより評価した。浴槽に40℃180Lのお湯を入れ、浴用剤組成物を投入した後、速やかにパネラーを入浴させ、入浴直後の温まり感を下記の基準で評価し、10名の平均値を評価点とした。
5:温まる。
4:やや温まる。
3:さら湯と同等。
2:さら湯と比べてやや温まらない。
1:さら湯と比べて温まらない。
《Degree of warming after bathing》
Evaluation was made by a total of 10 panelists from 20 to 40 years old. After putting hot water of 40 L at 40 ° C. into the bathtub and introducing the bath agent composition, the paneler was quickly bathed, and the warmth feeling immediately after bathing was evaluated according to the following criteria, and the average value of 10 persons was used as the evaluation score.
5: Warm up.
4: Slightly warms up.
3: Equivalent to Sarayu.
2: It does not warm a little compared with Sarayu.
1: Not warm compared with Sarayu.
《浴底溶け残り》
浴槽に40℃180Lのお湯を入れ、浴用剤組成物を投入して、充分に攪拌し、投入後から4分経過した時点での浴底の溶け残りを下記の基準で評価し、10名の平均値を評価点とした。
5:溶け残り多量に有り。
4:溶け残りが少々ありザラツキが気になる。
3:溶け残りが少々あるが気になる程ではない。
2:溶け残りがほとんど無い。
1:溶け残りが全く無い。
《Bath bottom unmelted》
Put hot water of 40L at 40 ° C into the bath, add the bath agent composition, stir well, and evaluate the undissolved residue at the bottom of the bath when 4 minutes have passed since the addition according to the following criteria. The average value was used as the evaluation score.
5: There is a large amount of unmelted residue.
4: There is a little unmelted and I am worried about the roughness.
3: There is a little undissolved, but not enough.
2: Almost no unmelted residue.
1: There is no undissolved residue.
表1〜2によれば、本発明の浴用剤組成物を用いれば、浴底での溶け残りもなく、微細な炭酸ガスの泡が大量に発生して、浴後の優れた温まり感を実感することができる。 According to Tables 1 and 2, if the bath agent composition of the present invention is used, there is no undissolved residue at the bottom of the bath, and a large amount of fine carbon dioxide bubbles are generated, realizing an excellent warm feeling after bathing. be able to.
Claims (6)
(A)有機酸、水溶性バインダー及び4〜30質量%の非イオン界面活性剤を含む造粒物、並びに
(B)炭酸塩
を含有する粒状浴用剤組成物。 The following components (A) and (B):
(A) A granulated product containing an organic acid, a water-soluble binder and 4 to 30% by mass of a nonionic surfactant, and (B) a granular bath composition containing a carbonate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010285331A JP5727214B2 (en) | 2010-12-22 | 2010-12-22 | Granular bath agent composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010285331A JP5727214B2 (en) | 2010-12-22 | 2010-12-22 | Granular bath agent composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012131740A true JP2012131740A (en) | 2012-07-12 |
JP5727214B2 JP5727214B2 (en) | 2015-06-03 |
Family
ID=46647784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010285331A Active JP5727214B2 (en) | 2010-12-22 | 2010-12-22 | Granular bath agent composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5727214B2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013091570A (en) * | 2013-01-15 | 2013-05-16 | Kazuo Hanno | Magnetic pole changing type inverter controlled rail motor device for elevator which can be emergency stopped and controlled with mobile phone and mobile wireless device |
JP2014043410A (en) * | 2012-08-27 | 2014-03-13 | Bathclin Corp | Briquette-type bathing agent |
JP5544672B1 (en) * | 2013-09-26 | 2014-07-09 | 株式会社東洋新薬 | Effervescent skin external preparation |
JP2014193934A (en) * | 2013-01-22 | 2014-10-09 | Toyo Shinyaku Co Ltd | Sparkling topical agent |
JP2015071550A (en) * | 2013-10-02 | 2015-04-16 | 花王株式会社 | Granular bath agent composition |
JP2015231963A (en) * | 2014-06-09 | 2015-12-24 | 花王株式会社 | Bath agent composition |
JP2020132574A (en) * | 2019-02-20 | 2020-08-31 | 花王株式会社 | Solid bath agent |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01238520A (en) * | 1988-03-17 | 1989-09-22 | Kao Corp | Bathing agent |
JPH03109317A (en) * | 1989-09-21 | 1991-05-09 | Kao Corp | Bathing agent |
JPH03112922A (en) * | 1989-09-25 | 1991-05-14 | Nissan Setsuken Kk | Foamable bathing agent for inhibiting floating of fumaric acid |
JP2004131455A (en) * | 2002-10-15 | 2004-04-30 | Kao Corp | Powdery or granular bathing agent |
JP2005200350A (en) * | 2004-01-15 | 2005-07-28 | Asahi Kasei Life & Living Corp | Carbonated leg bath preparation |
WO2009031535A1 (en) * | 2007-09-06 | 2009-03-12 | Tsumura Lifescience Co., Ltd. | Bubble-forming granule and bath additive composition |
JP2009155213A (en) * | 2007-12-25 | 2009-07-16 | Kao Corp | Granular bath agent composition |
JP2010215551A (en) * | 2009-03-16 | 2010-09-30 | Kao Corp | Bath medicine composition |
JP2012020951A (en) * | 2010-07-13 | 2012-02-02 | Kao Corp | Granular bathing agent composition |
-
2010
- 2010-12-22 JP JP2010285331A patent/JP5727214B2/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01238520A (en) * | 1988-03-17 | 1989-09-22 | Kao Corp | Bathing agent |
JPH03109317A (en) * | 1989-09-21 | 1991-05-09 | Kao Corp | Bathing agent |
JPH03112922A (en) * | 1989-09-25 | 1991-05-14 | Nissan Setsuken Kk | Foamable bathing agent for inhibiting floating of fumaric acid |
JP2004131455A (en) * | 2002-10-15 | 2004-04-30 | Kao Corp | Powdery or granular bathing agent |
JP2005200350A (en) * | 2004-01-15 | 2005-07-28 | Asahi Kasei Life & Living Corp | Carbonated leg bath preparation |
WO2009031535A1 (en) * | 2007-09-06 | 2009-03-12 | Tsumura Lifescience Co., Ltd. | Bubble-forming granule and bath additive composition |
JP2009155213A (en) * | 2007-12-25 | 2009-07-16 | Kao Corp | Granular bath agent composition |
JP2010215551A (en) * | 2009-03-16 | 2010-09-30 | Kao Corp | Bath medicine composition |
JP2012020951A (en) * | 2010-07-13 | 2012-02-02 | Kao Corp | Granular bathing agent composition |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014043410A (en) * | 2012-08-27 | 2014-03-13 | Bathclin Corp | Briquette-type bathing agent |
JP2013091570A (en) * | 2013-01-15 | 2013-05-16 | Kazuo Hanno | Magnetic pole changing type inverter controlled rail motor device for elevator which can be emergency stopped and controlled with mobile phone and mobile wireless device |
JP2014193934A (en) * | 2013-01-22 | 2014-10-09 | Toyo Shinyaku Co Ltd | Sparkling topical agent |
JP2014193842A (en) * | 2013-01-22 | 2014-10-09 | Toyo Shinyaku Co Ltd | Sparkling topical agent |
JP2017105864A (en) * | 2013-01-22 | 2017-06-15 | 株式会社東洋新薬 | Foaming external preparation for skin |
JP5544672B1 (en) * | 2013-09-26 | 2014-07-09 | 株式会社東洋新薬 | Effervescent skin external preparation |
JP2015067545A (en) * | 2013-09-26 | 2015-04-13 | 株式会社東洋新薬 | Foam-type external preparation for skin |
JP2015071550A (en) * | 2013-10-02 | 2015-04-16 | 花王株式会社 | Granular bath agent composition |
JP2015231963A (en) * | 2014-06-09 | 2015-12-24 | 花王株式会社 | Bath agent composition |
JP2020132574A (en) * | 2019-02-20 | 2020-08-31 | 花王株式会社 | Solid bath agent |
JP7217167B2 (en) | 2019-02-20 | 2023-02-02 | 花王株式会社 | Solid bath agent |
Also Published As
Publication number | Publication date |
---|---|
JP5727214B2 (en) | 2015-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5534988B2 (en) | Granular bath agent composition | |
JP5727214B2 (en) | Granular bath agent composition | |
JP5719532B2 (en) | Method for producing foamable powder bath composition | |
JP5883655B2 (en) | Method for producing foaming bath agent composition | |
JP5441529B2 (en) | Granular foam bath agent | |
JP5412220B2 (en) | Organic acid-containing granules | |
JP2012001469A (en) | Method for manufacturing granulated substance for bathing agent | |
JP6629652B2 (en) | Effervescent tablet type bath composition | |
JP6617064B2 (en) | Bath agent composition | |
JP6320017B2 (en) | Bath agent composition | |
JP6301623B2 (en) | Granular bath agent composition | |
JP6829620B2 (en) | Solid bath salt | |
JP2012144474A (en) | Method for manufacturing bubbling powder bathing agent composition | |
JP6829621B2 (en) | Bath preparation composition | |
JP2012072126A (en) | Thermoregulatory function improving agent | |
JP2013139396A (en) | Solid bathing agent | |
JP2014201540A (en) | Bathing agent composition | |
JP5291922B2 (en) | Lipophilic component-containing powder | |
JP6411779B2 (en) | Bath agent composition | |
JP5945133B2 (en) | Bath agent composition | |
JPH092942A (en) | Foaming tablet type bathing agent | |
JP6881928B2 (en) | Effervescent tablet bath composition | |
JP2013095709A (en) | Bathing agent for improving basal metabolism | |
JP2018089603A (en) | Method for producing granule | |
JP6617052B2 (en) | Carbon dioxide foaming bath composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20131025 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140625 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140729 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140918 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150317 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150402 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5727214 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |